Second Circuit Affirms "Pay for Delay" Dismissal: On May 13, 2024, the Second Circuit affirmed dismissal of antitrust claims brought by wholesalers, retailers, and employee benefit funds that alleged...

As a member of WIPO and a signatory of the 2006 Singapore Treaty on the Law of Trademarks, Russia recognizes and protects trademarks, both international and domestic, in a manner similar to that of most other WIPO countries.

The many issues raised by Cum-Ex were analysed in depth during Rahman Ravelli's online event examining the rapidly-developing, Europe-wide tax investigation.

On June 2, 2020, Judge Yvonne Gonzalez Rogers of the Northern District of California granted in part a motion to dismiss a putative securities class action asserting claims...

Beyond well-known antitrust exemptions like state-action immunity and the baseball exemption, Congress has carved out numerous lesser-known immunities for specific industries and activities.

On December 11, 2023, Judge Charles Breyer of the United States District Court for the Northern District of California narrowed a putative class action asserting claims under the Securities Exchange Act of 1934...

The United States Department of Justice Antitrust Division (DOJ) has issued a second Business Review Letter pursuant to the expedited review process it announced on March 24, 2020

On March 24, 2020, the US Federal Trade Commission (FTC) and US Department of Justice (DOJ) issued a Joint Antitrust Statement Regarding COVID-19.

The Seventh Circuit issued this week a long-awaited opinion in the HUMIRA antitrust litigation, UFCW Local 1500 Welfare Fund v. AbbVie Inc., Case No. 20-2402.

On Monday, December 10, 2012, the Federal Trade Commission and the Antitrust Division of the Department of Justice held a joint workshop (Agenda) on the activities of patent assertion entities ("PAEs").

On August 26, 2013, in Waugh Chapel South, LLC v. UFCW, the U.S. Court of Appeals for the Fourth Circuit delivered a victory, in part, to employers and, in part, to labor.

Welcome to "CEQA News You Can Use," a quarterly production of Brownstein Hyatt Farber Schreck, LLP's Natural Resources lawyers.

The Federal Trade Commission (FTC) submitted comments supporting the Food and Drug Administration's (FDA)

Generative AI (GenAI) is transforming how competition-related cases, including merger control and investigations, are handled.

On June 8, 2020, an Illinois Federal District Court Judge dismissed without prejudice a Complaint by indirect purchasers of the autoimmune disorder ...

Recently, there have been rumblings of antitrust enforcement in response to the increasing prominence of corporate policies furthering environmental, social and governance goals.

In a memorandum issued on 21 February 2025 and titled "America First Investment Policy", President Trump set out his administration's new policy towards foreign investment into the US.

Artificial intelligence pacing agreements among frontier AI laboratories raise complex antitrust questions under the Sherman Act, as coordinated commitments to slow capability development can be characterized as competitor agreements to restrict output. While existing statutory safe harbors provide only partial protection, companies must navigate significant legal risks spanning intellectual property, export controls, fiduciary duties, and international AI regulation when considering participation in such a

The Antitrust Division of the DOJ and the FTC announced they are seeking public comments on the first update to the Antitrust Guidelines for the Licensing of Intellectual Property issued in 1995.